Rights and permissions
About this article
Cite this article
Anagrelide cost-effective alternative for thrombocythemia?. Pharmacoecon. Outcomes News 373, 7 (2002). https://doi.org/10.1007/BF03279383
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279383